441798-33-0
441798-33-0
Chemical Structure
Macitentan
Synonym(s): ACT-064992
- CAS No.: 441798-33-0
- Formula:C19H20Br2N6O4S
- Molecular Weight:588.27
InChIKey: JGCMEBMXRHSZKX-UHFFFAOYSA-N
SMILES: BrC1=CN=C(OCCOC2=C(C3=CC=C(Br)C=C3)C(NS(NCCC)(=O)=O)=NC=N2)N=C1
Biological Activity: Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Macitentan | 99.85% | Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Macitentan (Standard) | 99.79% | Macitentan (Standard) is the analytical standard of Macitentan. This product is intended for research and analytical applications. Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Macitentan-d4 | 99.85% | Macitentan-d4 is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
